Medtronic Clinical Solutions GYN & Women’s Health Hysteroscopy Conditions & Clinical Applications

Abnormal Uterine Bleeding (AUB)

An estimated 100 million women globally live with abnormal uterine bleeding (AUB).1 Eighty-eight percent of those women opt to wait and do not seek treatment immediately.([FOOTNOTE=Based on internal analysis of 2017 market model data. April 2018.],[ANCHOR=],[LINK=]) Yet, millions of them could alleviate their symptoms with hysteroscopy, especially when their AUB is likely caused by/could be caused by pathology such as endometrial polyps, fibroids or retained products of conception.

Procedural Videos

1:59
watched

TruClear™ 8.0 system and TruClear™ soft tissue shavers
1:50
watched

TruClear™ Elite hysteroscope mini and TruClear™ soft tissue shaver
2:33
watched

TruClear™ Elite Mulitple Myomectomy
Visual D&C

A clear alternative to blind D&C

She deserves effective removal and accurate diagnosis of her intrauterine pathology. That’s why treatment without direct visualization should no longer be the norm.

With blind D&C, research shows:

  • Low diagnostic accuracy([FOOTNOTE=Epstein E, Ramirez A, Skoog L, Valentin L. Dilatation and curettage fails to detect most focal lesions in the uterine cavity in women with postmenopausal bleeding. Acta Obstet Gynecol Scand. 2001;80(12):1131–1136.],[ANCHOR=],[LINK=])
  • Incomplete resection of pathology†,2,([FOOTNOTE=Bettocchi et al. Diagnostic Inadequacy of Dilatation & Curettage, Fertil Steril 2001;75:803-805.],[ANCHOR=],[LINK=])
Visual D&C

Hysteroscopy offers more accurate diagnosis, and more complete resection

Read more about increasing your assurance in a familiar procedure in this visual D&C brochure.
View Brochure

Patient Materials for AUB

We've created these materials to help explain AUB and hysteroscopic procedures to your patients. Contact your rep for more information.

Find Your Rep

TruClear™ System AUB Patient Brochure

Hysteroscopy with the TruClear™ system means no incisions, no electrical scarring within the uterus, and no extended hospital recovery. 

View Brochure

TruClear™ System AUB Patient Flip Chart

Get back to your best life. It’s possible with the TruClear™ system. Read more.

View Chart

Patient Video: Information for GYN Procedures

Treat your abnormal uterine bleeding. Get back to your best life.

Watch Video

Retained Products of Conception (RPOC)

Today, D&C is a common approach for management of retained products of conception (RPOC).  A 2015 publication shows D&C is associated with a higher incidence of moderate intrauterine adhesions and incomplete evacuation compared with hysteroscopic resection in women treated for RPOC.([FOOTNOTE=Hooker A, Aydin H, Brohlmann H, and Huirne J. Long-term complications and reproductive outcome after the management of retained products of conception: a systematic review. Fertility and Sterility. 2016. 105(1), 156-164.],[ANCHOR=],[LINK=])

Hear how Aaron Styer, MD, uses the TruClear™ system to remove RPOC.

Video: TruClear™ System RPOC Evacuation Procedure

Dr. Kathryn Ray procedural video featuring multiple polypectomy using TruClear™ 8.0 system and TruClear™ soft tissue shaver plus.

Watch Video

Retained Products Conception Information Sheet

When it comes to miscarriage management and treatment of retained products of conception (RPOC), women deserve the most effective and efficient treatment.

View Info Sheet

Contemporary OBGYN Article

The role of hysteroscopy in managing miscarriage.

Learn More

Podcast Series

Better For Women: Contemporary OBGYN

Listen to Dr. Ido Sirota, MD, MHA, FACOG, the Division Director of Minimally Invasive Gynecologic Surgery and Robotics at New York-Presbyterian Queens. He specializes in advanced Minimally Invasive Gynecologic Surgery with focus on elevating gynecologic surgery by offering state-of-the-art surgical treatment for women.

Listen to Podcast

Hysteroscopy

Diagnosis and treatment of intrauterine pathology.

In-Office Procedures

Bringing hysteroscopy procedures from the hospital to the office.

Products

A dedicated suite of GYN products.

Education & Training

Paving the path to less invasive surgeries.

  • † In a study of postmenopausal women, whole or parts of the lesion in situ after a D&C in 87% of patients.

Corporate Resources
HCP Resources
Patient Resources
Additional Resources
Operational Headquarters

710 Medtronic Parkway

Minneapolis, MN

55432-5604

USA

©2021 Medtronic